217 related articles for article (PubMed ID: 23939304)
21. PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease.
Ge P; Dawson VL; Dawson TM
Mol Neurodegener; 2020 Mar; 15(1):20. PubMed ID: 32169097
[TBL] [Abstract][Full Text] [Related]
22. [Parkin and mitochondria].
Mitsui T; Kuroda Y; Kaji R
Brain Nerve; 2008 Aug; 60(8):923-9. PubMed ID: 18717196
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
Trancikova A; Tsika E; Moore DJ
Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447
[TBL] [Abstract][Full Text] [Related]
24. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
25. Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease.
Pilsl A; Winklhofer KF
Acta Neuropathol; 2012 Feb; 123(2):173-88. PubMed ID: 22057787
[TBL] [Abstract][Full Text] [Related]
26. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.
Exner N; Treske B; Paquet D; Holmström K; Schiesling C; Gispert S; Carballo-Carbajal I; Berg D; Hoepken HH; Gasser T; Krüger R; Winklhofer KF; Vogel F; Reichert AS; Auburger G; Kahle PJ; Schmid B; Haass C
J Neurosci; 2007 Nov; 27(45):12413-8. PubMed ID: 17989306
[TBL] [Abstract][Full Text] [Related]
27. PINK1 protein in normal human brain and Parkinson's disease.
Gandhi S; Muqit MM; Stanyer L; Healy DG; Abou-Sleiman PM; Hargreaves I; Heales S; Ganguly M; Parsons L; Lees AJ; Latchman DS; Holton JL; Wood NW; Revesz T
Brain; 2006 Jul; 129(Pt 7):1720-31. PubMed ID: 16702191
[TBL] [Abstract][Full Text] [Related]
28. The Michael J. Fox Foundation for Parkinson's Research Strategy to Advance Therapeutic Development of PINK1 and Parkin.
Padmanabhan S; Polinski NK; Menalled LB; Baptista MAS; Fiske BK
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31344817
[TBL] [Abstract][Full Text] [Related]
29. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson's disease.
Corti O; Brice A
Curr Opin Neurobiol; 2013 Feb; 23(1):100-8. PubMed ID: 23206589
[TBL] [Abstract][Full Text] [Related]
31. Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss.
Biosa A; Sanchez-Martinez A; Filograna R; Terriente-Felix A; Alam SM; Beltramini M; Bubacco L; Bisaglia M; Whitworth AJ
Hum Mol Genet; 2018 May; 27(9):1618-1629. PubMed ID: 29529199
[TBL] [Abstract][Full Text] [Related]
32. [The role of parkin in Parkinson's disease].
Miklya I; Göltl P; Hafenscher F; Pencz N
Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
[TBL] [Abstract][Full Text] [Related]
33. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
Yasuda T; Mochizuki H
Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
[TBL] [Abstract][Full Text] [Related]
34. Molecular insights into Parkinson's disease.
Rochet JC; Hay BA; Guo M
Prog Mol Biol Transl Sci; 2012; 107():125-88. PubMed ID: 22482450
[TBL] [Abstract][Full Text] [Related]
35. Genetic mutations and functions of PINK1.
Kawajiri S; Saiki S; Sato S; Hattori N
Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
[TBL] [Abstract][Full Text] [Related]
36. Activation mechanisms of the E3 ubiquitin ligase parkin.
Panicker N; Dawson VL; Dawson TM
Biochem J; 2017 Aug; 474(18):3075-3086. PubMed ID: 28860335
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice.
Khang R; Park C; Shin JH
Neuroscience; 2015 May; 294():182-92. PubMed ID: 25779963
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease.
Dave KD; De Silva S; Sheth NP; Ramboz S; Beck MJ; Quang C; Switzer RC; Ahmad SO; Sunkin SM; Walker D; Cui X; Fisher DA; McCoy AM; Gamber K; Ding X; Goldberg MS; Benkovic SA; Haupt M; Baptista MA; Fiske BK; Sherer TB; Frasier MA
Neurobiol Dis; 2014 Oct; 70():190-203. PubMed ID: 24969022
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
40. Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease.
Ahlskog JE
Parkinsonism Relat Disord; 2009 Dec; 15(10):721-7. PubMed ID: 19815446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
